Images List Premium Download Classic

Immunotherapy

Immunotherapy-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Crispr-cas-related methods, compositions and components for cancer immunotherapy
Editas Medicine, Inc.
June 22, 2017 - N°20170175128

Crispr/cas-related composition and methods for treatment of cancer, in particular by using grna molecules comprising a targeting domain which is complementary with a target domain from the fas, bid, ctla4, pdcd1, cblb, ptpn6, trac or trbc gene. In some embodiments, grnas are used with cas9 enzymes to cause a cleavage event in said genes within engineered chimeric antigen receptor (...
Bi-terminal pegylated integrin-binding peptides and methods of use thereof
The Regents Of The University Of California
June 22, 2017 - N°20170174723

The present invention provides bi-terminal pegylated peptide conjugates that target an integrin such as αvβ6 integrin. In particular embodiments, the peptide conjugates of the present invention further comprise a biological agent such as an imaging agent or a therapeutic agent, e. G., covalently attached to one of the peg moieties. The peptide conjugates of the present ...
Cancer immunotherapy compositions and methods
The Regents Of The University Of Michigan
June 22, 2017 - N°20170173180

The present invention relates to compositions and methods for cancer immunotherapy. In particular, the present invention relates to engineered effector b cells and their use in cancer immunotherapy.
Immunotherapy Patent Pack
Download 225+ patent application PDFs
Immunotherapy Patent Applications
Download 225+ Immunotherapy-related PDFs
For professional research & prior art discovery
inventor
  • 225+ full patent PDF documents of Immunotherapy-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Novel peptides and combination of peptides for use in immunotherapy against breast cancer and other ...
Immatics Biotechnologies Gmbh
June 22, 2017 - N°20170173132

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated t-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor ...
Novel peptides and combination of peptides for use in immunotherapy against cll and other cancers
Immatics Biotechnologies Gmbh
June 22, 2017 - N°20170173131

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated t-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor ...
Method of ex vivo enhancement of immune cell activity for cancer immunotherapy with a small ...
Provectus Pharmatech, Inc.
June 22, 2017 - N°20170173079

A cancer immunotherapy method is disclosed in which “induced immune anticancer agents” are isolated after being induced in an animal host by intralesional (il) administration of a halogenated xanthene tumor-ablative compound into a solid cancerous tumor of that host animal. A sample of the induced immune anticancer agents is removed (collected) from the tumor-bearing host, banked ...
Immunotherapy Patent Pack
Download 225+ patent application PDFs
Immunotherapy Patent Applications
Download 225+ Immunotherapy-related PDFs
For professional research & prior art discovery
inventor
  • 225+ full patent PDF documents of Immunotherapy-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Macrophage car (moto-car) in immunotherapy
Provectus Pharmatech, Inc.
June 15, 2017 - N°20170166657

Modified macrophage immune cells are provided for treatment of cancer and other diseases.
Human-derived anti-huntingtin (htt) antibodies and uses thereof
Neurimmune Holding Ag
June 15, 2017 - N°20170166631

Provided are novel human-derived anti-huntingtin (htt) antibodies and biotechnological derivatives thereof, preferably capable of binding mutated and/or aggregated htt species and or fragments thereof, as well as methods related thereto. The human-derived anti-htt antibodies and biotechnological derivatives can be used in pharmaceutical and diagnostic compositions for htt targeted immunotherapy of huntington disease and diagnosis thereof.
Cancer-targeted il-12 immunotherapy
Merck Patent Gmbh
June 15, 2017 - N°20170166620

The invention is directed to cancer immunotherapy. The invention is specifically directed to the induction of innate or adaptive antitumor immunity initiated by the administration of targeted il-12 molecules preferably in conjunction with il-2 and/or il-7 to a cancer patient, who suffers from cancer of the muscle, bone, nerves, cartilage, tendons, blood vessels, etc., preferably from sarcoma. The invention ...
Immunotherapy composition and use thereof
Ondek Pty Ltd
June 15, 2017 - N°20170165357

The present invention relates to the field of preventing or reducing incidence or severity of an allergic immune response, and compositions for preventing or reducing incidence or severity of an allergic immune response. For example, the present invention provides compositions comprising inactivated and/or killed cells of helicobacter pylori or a cell lysate thereof, and methods and/or uses thereof ...
Novel peptides and combination of peptides for use in immunotherapy against cll and other cancers
Immatics Biotechnologies Gmbh
June 15, 2017 - N°20170165340

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated t-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor ...
Novel peptides and combination of peptides for use in immunotherapy against various cancers
Immatics Biotechnologies Gmbh
June 15, 2017 - N°20170165339

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated t-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor ...
Novel peptides and combination of peptides for use in immunotherapy against various cancers
Immatics Biotechnologies Gmbh
June 15, 2017 - N°20170165338

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated t-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor ...
Immunotherapy Patent Pack
Download 225+ patent application PDFs
Immunotherapy Patent Applications
Download 225+ Immunotherapy-related PDFs
For professional research & prior art discovery
inventor
  • 225+ full patent PDF documents of Immunotherapy-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other ...
Immatics Biotechnologies Gmbh
June 15, 2017 - N°20170165335

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated t-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor ...
Method for the treatment of bladder cancer
Cipla Limited
June 15, 2017 - N°20170165257

Methods of treating bladder cancer using terconazole are disclosed herein. Terconazole can be administered as part of a comprehensive treatment program, which can also include chemotherapy, immunotherapy, radiation therapy and/or surgical treatment.
Novel peptides and combination of peptides for use in immunotherapy against various tumors
Immatics Biotechnologies Gmbh
June 08, 2017 - N°20170158750

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated t-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor ...
Methods of growing tumor infiltrating lymphocytes in gas-permeable containers
Wilson Wolf Manufacturing Corporation
June 01, 2017 - N°20170152478

An embodiment of the invention provides a method of promoting regression of cancer in a mammal comprising obtaining a tumor tissue sample from the mammal; culturing the tumor tissue sample in a first gas permeable container containing cell medium therein; obtaining tumor infiltrating lymphocytes (til) from the tumor tissue sample; expanding the number of til in a second gas permeable ...
Galectin immunotherapy
The Council Of The Queensland Institute Of Medical Research
June 01, 2017 - N°20170152317

A method of modulating immunity in a mammal is provided by modulating galectin-9 activity in the mammal. Promoting or enhancing immunity may be effected by activating or stimulating galectin-9 activity in the mammal, such as by administering a galectin-9 agonist to the mammal. The agonist may be multimeric, soluble pd-l2 or an agonist antibody that binds galectin-9. Suppressing or preventing ...
Tdp-43 specific binding molecules
University Of Zurich
June 01, 2017 - N°20170152308

Provided are novel tdp-43-specific binding molecules including polypeptides such as human antibodies, as well as fragments, derivatives and variants thereof. Also provided are methods related to these tdp-43 specific binding molecules. Assays, kits, and solid supports related to tdp-43-specific binding molecules, including polypeptides such as, human antibodies are also disclosed. The tdp-43-specific binding molecule, antibody, immunoglobulin chain(...
Drug regulated transgene expression
Seattle Children's Hospital (dba Seattle Children's Research Institute)
June 01, 2017 - N°20170152297

The present invention provides nucleic acids, vectors, host cells, methods and compositions to confer and/or augment immune responses mediated by cellular immunotherapy, such as by adoptively transferring cd8+ central memory t cells or combinations of central memory t cells with cd4+ t cells that are genetically modified to express a chimeric receptor under the control of an inducible promoter. ...
Chimeric antigen receptor hcd87-car and applications thereof
Seattle Children's Hospital (dba Seattle Children's Research Institute)
May 25, 2017 - N°20170145106

The present invention relates to a cellular immunotherapy for treatment of tumors, particularly to a peptide of a chimeric antigen receptor hcd87-car and the applications thereof, the peptide of said antigen receptor being carried by a vector packaged in a lentivirus. The chimeric antigen receptor hcd87-car contains a fragment of anti cd87 monoclonal antibody hcd87scfv consisting of ...
Loading